differentiated thyroid gland carcinoma (Cancer)
Information
- Disease name
- differentiated thyroid gland carcinoma
- Disease ID
- DOID:0080525
- Description
- "A thyroid gland adenocarcinoma characterized by extensive evidence of follicular cell differentiation." [url:https\://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C7153&ns=ncit]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00381641 | Active, not recruiting | Phase 2 | Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery | August 8, 2006 | March 8, 2025 |
| NCT03914300 | Active, not recruiting | Phase 2 | Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer | February 10, 2020 | October 31, 2024 |
| NCT02592356 | Completed | N/A | Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer | November 16, 2015 | March 1, 2024 |
| NCT05575440 | Recruiting | Evaluation of 18F-TFB PET/CT Scan in Patients With Differentiated Thyroid Cancer | April 22, 2022 | May 1, 2026 | |
| NCT03506048 | Terminated | Phase 2 | Lenvatinib and Iodine Therapy in Treating Patients With Radioactive Iodine-Sensitive Differentiated Thyroid Cancer | January 16, 2019 | June 24, 2021 |
- Disase is a (Disease Ontology)
- DOID:0080524
- Cross Reference ID (Disease Ontology)
- NCI:C7153